By Benjamin Chiou
Date: Friday 26 Jun 2026
(Sharecast News) - The European Commission on Friday opened a formal antitrust investigation into whether French drugmaker Sanofi breached EU competition rules through the marketing of its influenza vaccine.
By Frank Prenesti
Date: Thursday 23 Apr 2026
(Sharecast News) - Shares in Sanofi rose as the French pharma giant beat first-quarter sales estimates on Thursday on continuing demand for its Dupixent asthma and eczema drug just before the arrival of new chief executive Belén Garijo.
By Josh White
Date: Thursday 29 Jan 2026
(Sharecast News) - Sanofi reported strong fourth-quarter and full-year results for 2025 on Thursday, underpinned by robust growth from its blockbuster asthma and dermatology treatment Dupixent, while forecasting another year of profitable growth in 2026 despite lingering concerns over its pipeline and vaccine demand.
| Currency | Euro |
| Share Price | 78.56 |
| Change Today | 0.89 |
| % Change | 1.15 % |
| 52 Week High | 90.44 |
| 52 Week Low | 72.41 |
| Volume | 1,787,672 |
| Shares Issued | 1,220.40m |
| Market Cap | 95,875m |
| Beta | 0.07 |
| Time | Volume / Share Price |
| 17:37 | 55 @ 78.56 |
| 17:37 | 75 @ 78.56 |
| 17:37 | 75 @ 78.56 |
| 17:37 | 75 @ 78.56 |
| 17:37 | 75 @ 78.56 |
You are here: research